Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $85
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $90 to $85.
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $90 to $85.